Skip to the main content.

Cell and Gene Therapy Series. Part 2

Dr. Dave Seaward : 20 January 2022

Cell and Gene Therapy Series. Part 2

PDF File: Cell and Gene Therapy: What are ATMPs and why do they matter?

Welcome to part 2 of our Cell and Gene blog series. Click the pdf link above to access the second blog.

This second blog provides a primer to 'ATMPs', looking at what they are why they matter. The reader will get an insight into some of the historical context and various technologies behind ATMPs.
Interview with Alex Jezequel, Projects Director at 3P innovation: roboFIL™: revolutionising pharmaceutical fill-finish operations.

Interview with Alex Jezequel, Projects Director at 3P innovation: roboFIL™: revolutionising pharmaceutical fill-finish operations.

Alex Jezequel: 15 April 2025

Alex Jezequel talks about designing roboFIL™ In the ever-evolving pharmaceutical manufacturing landscape, 3P innovation is making waves with its...

Aseptic Fill-Finish robotics
Read More
Understanding aseptic powder filling: Key principles & techniques

Understanding aseptic powder filling: Key principles & techniques

David Johnson: 25 September 2024

Aseptic powder filling is a critical step in pharmaceutical production, particularly for medications that require sterile administration such as...

Read More
Shaping the future of ATMPs: tailored automation and advanced technologies for the next decade

Shaping the future of ATMPs: tailored automation and advanced technologies for the next decade

Dr. Dave Seaward: 30 September 2024

If history is to repeat itself, the next 10 years will see significant activity regarding the automation of advanced therapy medicinal products (ATMPs

Read More